Q32 Bio (QTTB) Return on Sales (2018 - 2024)

Q32 Bio's Return on Sales history runs 7 years deep, the most recent figure standing at 0.43% for Q3 2024.

• In Q3 2024, Return on Sales rose 51.0% year-over-year to 0.43%; the TTM figure through Sep 2024 stood at 0.43% (up 50.0% YoY), while the FY2025 annual figure was 0.01%, changed N/A from the prior year.
• Return on Sales was 0.43% for Q3 2024 at Q32 Bio, up from 1.11% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 1.16% in Q1 2022 to a low of 1.11% in Q2 2024.
• Historically, Return on Sales has averaged 0.18% across 5 years, with a median of 0.18% in 2021.
• The sharpest annual moves came in 2022 and 2023: Return on Sales soared 116 bps in 2022, then slumped 118 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.3% in 2020, then sank by 38 bps to 0.42% in 2021, then slipped by 3 bps to 0.43% in 2022, then soared by 146 bps to 0.2% in 2023, then soared by 118 bps to 0.43% in 2024.
• The last three Return on Sales figures came in at 0.43% (Q3 2024), 1.11% (Q2 2024), and 0.12% (Q1 2024), per Business Quant data.